WAYLAND, Mass.--(BUSINESS WIRE)--Feb. 1, 2005-- Candela Corporation (NASDAQ: CLZR) announced today that it will introduce next generation I2PL technology for skin rejuvenation of vascular and pigmented abnormalities. Through a partnership with Danish Dermatologic Development A/S (DDD), Candela will expand its product portfolio to include the new Ellipse I2PL system. Candela is the exclusive distributor for the new Ellipse intense pulsed light system in the United States.
